Acneiform eruption induced by Iressa (gefitinib) tablets used to treat non-small cell lung cancer
Warthan, M.M.; Jumper, C.A.; Smith, J.L.
Journal of drugs in dermatology JDD 3(5): 569-570
2004
ISSN/ISBN: 1545-9616 PMID: 15552613 Document Number: 8193
Many medications have been reported to induce acneiform eruptions. A relatively new chemotherapy drug, gefitinib (Iressa), approved by the Food and Drug Administration in 2003 for the treatment of advanced-stage non-small cell lung cancer (NSCLC), has been reported to cause acne or an acne-like eruption. We report an Asian female who presented with hundreds of erythematous papules and pustules on her face, chest, and back, all of which appeared after starting gefitinib to treat non-small cell lung cancer.
Document emailed within 1 workday
Related Documents
Nakagawa, K. 2004: Gefitinib in non-small cell lung cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 62(7): 1312-1320Tanović, A.; Alfaro, V. 2004: Gefitinib: current status in the treatment of non-small cell lung cancer Drugs of Today 40(10): 809-827
Wang, B.; Zhang, X-ru.; Chu, D-tong. 2007: Gefitinib in the treatment of male patients with advanced non-small-cell lung cancer Zhonghua Zhong Liu Za Zhi 29(7): 549-551
Hashizume, T.; Ogura, T.; Kozawa, S.; Kobayashi, N.; Tagawa, A.; Miyazawa, N.; Watanuki, Y.; Takahashi, H. 2006: Gefitinib as a first-line therapy in patients with advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(4): 467-470
Gu, A.-q.; Wang, H.-m.; Shi, C.-l.; Xiong, L.-w.; Gao, Z.-q.; Han, B.-h. 2010: Clinical observation of gefitinib for the treatment of 125 cases with advanced non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 32(1): 71-74
Nishikawa, M.; Kusano, N.; Yoshimoto, N.; Ito, M.; Kakemizu, N.; Nozaki, M.; Fujiwara, M.; Momiyama, M.; Kido, Y. 2006: Prolonged survival of gefitinib treatment in patients with advanced and previously treated non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(10): 1437-1440
Mencoboni, M.; Bergaglio, M.; Serra, M.; Ivaldi, G.P.; Tredici, S.; Racchi, O.; Rebella, L.; Galbusera, V.; Grosso, M.; Faravelli, B. 2007: Maintenance therapy with gefitinib after first-line chemotherapy in patients affected by advanced non-small cell lung cancer Anticancer Research 27(6c): 4425-4429
Zhang, L.; Wang, S.-L.; Zhang, X.-T.; Li, L.-Y.; Wang, M.-Z. 2007: Efficacy and safety of gefitinib monotherapy for Chinese elderly patients with advanced non-small cell lung cancer Zhonghua Nei Ke Za Zhi 46(5): 392-395
Fujimoto, H.; Oyama, T.; Suito, T.; Hashimoto, K.; Kameyama, Y.; Yasuda, H.; Ishizuka, H. 2010: A case of complete response treated by S-1 with concurrent radiotherapy for a gefitinib-resistant non-small cell lung cancer patient Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(2): 295-298
Suzumura, T.; Kimura, T.; Kudoh, S.; Umekawa, K.; Nagata, M.; Tanaka, H.; Mitsuoka, S.; Yoshimura, N.; Kira, Y.; Hirata, K. 2012: Comparison of adverse events of erlotinib with those of gefitinib in patients with non-small cell lung cancer: a case-control study in a Japanese population Osaka City Medical Journal 58(1): 25-34
Epperly, M.W.; Franicola, D.; Zhang, X.; Nie, S.; Greenberger, J.S. 2006: Effect of EGFR antagonists gefitinib (Iressa) and C225 (Cetuximab) on MnSOD-plasmid liposome transgene radiosensitization of a murine squamous cell carcinoma cell line In Vivo 20(6b): 791-796
Acharyya, S.; Sau, S.; Dasgupta, P.; Chakraborty, A.; Gangopadhyay, S. 2012: Skin rash as a surrogate marker of clinical response of targeted therapy using gefitinib in advanced or metastatic non-small-cell lung cancer--a retrospective study Journal of the Indian Medical Association 110(7): 474-6 493
Aoe, K.; Hiraki, A.; Murakami, T.; Maeda, T.; Umemori, Y.; Katayama, H.; Eda, R.; Takeyama, H. 2005: Sudden onset of interstitial lung disease induced by gefitinib in a lung cancer patient with multiple drug allergy Anticancer Research 25(1b): 415-418
Protsenko, S.A.; Rudakova, A.V.; Moiseenko, F.V.; Levchenko, E.V.; Matsko, D.E.; Ivantsov, A.O.; Semënov, I.I.; Ievleva, A.G.; Mitiushkina, N.V.; Togo, A.V.; Novik, A.V.; Imianitov, E.N.; Moiseenko, V.M. 2012: Pharmacoeconomic analysis of gefitinib therapy in patients with non-cell cell lung cancer Voprosy Onkologii 58(3): 352-358
Neill, H.B.; Miller, A.A.; Clamon, G.H.; Perry, M.C.; Crawford, J.; Green, M.R. 1997: A phase Ii study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12
Munzuroglu, F.; Erturan, S.; Oz, B.; Dincbas, F.O.; Demir, G. 2009: Non small cell lung cancer within the small cell lung cancer radiotherapy field after 11 years Journal of Buon: Official Journal of the Balkan Union of Oncology 14(2): 313-316
Bando, T.; Fujimura, M.; Kasahara, K.; Matsuda, T. 1998: Significance of Na+, K(+)-ATPase on intracellular accumulation of cis-diamminedichloroplatinum(II) in human non-small-cell but not in small-cell lung cancer cell lines Anticancer Research 18(2a): 1085-1089
Pancrazio, J.J.; Viglione, M.P.; Kleiman, R.J.; Kim, Y.I. 1991: Verapamil-induced blockade of voltage-activated K+ current in small-cell lung cancer cells Journal of Pharmacology and Experimental Therapeutics 257(1): 184-191
Doyle, L.A.; Cuttitta, F.; Mulshine, J.L.; Bunn, P.A.; Minna, J.D. 1987: Markedly different antibody responses to immunized small cell and non-small cell lung cancer cells Cancer Research 47(19): 5009-5013
Kobyakov, D.S.; Avdalyan, A.M.; Lazarev, A.F.; Lushnikova, Y.L.; Nepomnyashikh, L.M. 2015: The Processes of cell Proliferation, Apoptosis and Angiogenesis in Pathologically Unchanged Lung and in Non-Small cell Lung Cancer Morfologiia 148(5): 65-70